COVID-19: Newly Published Research And CDC Data

 Recently, there have been a couple of interesting papers published concerning mRNA COVID-19 vaccines.

We linked the Georgia Immunization Registry with the Georgia Coverdell Acute Stroke Registry and the Georgia State Electronic Notifiable Disease Surveillance System data to assess the relative risk of stroke by the vaccine type.

Results: Approximately 5 million adult Georgians received at least one COVID-19 vaccine between 1 December 2020 and 28 February 2022: 54% received BNT162b2, 41% received mRNA-1273, and 5% received Ad26.COV2.S. Those with concurrent COVID-19 infection within 21 days post-vaccination had an increased risk of ischemic and hemorrhagic stroke with no evidence for interaction between the vaccine type and concurrent COVID-19 infection.

After adjusting for age, race, gender, and COVID-19 infection status, there was a 57% higher risk for ischemic stroke within 21 days of vaccination associated with the Ad26.COV2.S vaccine compared to BNT162b2; there was no difference in stroke risk between mRNA-1273 and BNT162b2.

After adjusting for age, race, gender, and COVID-19 infection status, those with concurrent COVID-19 infection had an increased risk of ischemic and hemorrhagic stroke.

Following the COVID-19 outbreak, numerous research studies have been conducted, shedding light on the potential role of breastfeeding in preventing infants from the illness.

More data from the CDC indicates that Americans are done with mRNA COVID-19 injections. 

https://rwmalonemd.substack.com/p/covid-19-newly-published-research?utm_source=post-email-title&publication_id=583200&post_id=135311077&isFreemail=true&utm_medium=email